DexCom Inc. DXCM recently announced the direct connectivity of the Dexcom G7 Continuous Glucose Monitoring (CGM) system with the Apple Watch. This added feature is now available to users in the United ...

DexCom Inc. DXCM recently announced the integration of its Dexcom G6 Continuous Glucose Monitor (CGM) system with Insulet’s Omnipod 5 Automated Insulin Delivery (AID) System for Type 1 diabetes ...

DexCom, Inc. DXCM recently announced that its next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System received Health Canada’s approval for people with all types of diabetes aged two ...

With more than 10 years of pioneering CGM market leadership in AID integration, Dexcom is the most studied CGM brand with AID capabilities and the clear choice for powering AID systems 3,4 The ...

SAN DIEGO - DexCom, Inc. (NASDAQ:DXCM), a $26.12 billion medical device company with 11.34% revenue growth over the last twelve months, announced the FDA clearance of its Dexcom G7 15 Day Continuous ...

EDINBURGH, Scotland–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today it has ended its ...

Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, applauds the progressive expansion of coverage for continuous glucose ...